The Ministry of Health withdraws these drugs because they contain carcinogens

The Ministry of Health said that the reported data interest several countries of the world after the component "N-nitrosodimethylamine" was detected in the active ingredient "Valsartan" manufactured by the Chinese company "Zhejing Huahai Pharmaceutical Co "" In accordance with the precautionary principle, the Directorate of Drugs and Pharmaceuticals of the Ministry of Health has withdrawn drugs containing valbadartan The company of the Chinese company "Zhejing Huahai Pharmaceutical Co", which is about "VALSARTAN WIN 80 mg; 160 mg "and" CO-VALSARTAN WIN 80 mg / 12.5 mg 160 mg / 25 mg "and" ATENSIL 40 mg; 80 mg;

The same source explained that these drugs are used to treat patients with high blood pressure to reduce complications such as heart attacks and strokes, and are used to treat patients suffering from arthritis. heart failure or a recent heart attack. The department recommended that patients who use these drugs consult a doctor to replace the drug with another drug, valsartan, from another source or alternative treatment, requesting discontinuation of the drug. processing